# Venus Pharmaceuticals International, Inc. – FDA Inspections

Source: https://www.keypedia.com/companies/venus-pharmaceuticals-international-inc/a95be337-7246-4fcd-aefb-b582aaebe7c2

> Inspection records and compliance data for Venus Pharmaceuticals International, Inc.. Access full analysis and detailed observations.

---

## Details

- Name: Venus Pharmaceuticals International, Inc.
- Country Name: United States
- Address: United States
- Country: United States

## Related Documents

- [WARNING_LETTER - Venus Pharmaceuticals International, Inc. - 2010-08-19](https://www.keypedia.com/records/warning_letter/venus-pharmaceuticals-international-inc/6ecdfdcc-6707-4657-8ed1-b869a7f6e774) — source: FDA, date: August 19, 2010

## Related Companies

- [Forbiddenlabz](https://www.keypedia.com/companies/forbiddenlabz/e036236e-ed4a-41a4-9678-b583645daba4)
- [ReConserve Inc.](https://www.keypedia.com/companies/reconserve-inc/ec4090f9-4bb6-426b-8287-5bcfe46362b0)
- [CrossRoads Extremity Systems, LLC](https://www.keypedia.com/companies/crossroads-extremity-systems-llc/62e7b9a4-7703-450f-b2b2-4497ffd71e09)
- [CueCig](https://www.keypedia.com/companies/cuecig/a6bfa5de-6d66-43bd-94eb-5b65f1b95561)
- [Mason Brothers Co](https://www.keypedia.com/companies/mason-brothers-co/51c4a7ff-3652-4432-973e-84a269cc1bbe)
- [Medela Inc](https://www.keypedia.com/companies/medela-inc/a1b3eb87-021e-4ebd-bba3-d057c02a4236)
- [Absolute Pharmacy, LLC](https://www.keypedia.com/companies/absolute-pharmacy-llc/00400f63-b956-4442-9bbd-89581160673e)
- [Curewave Lasers LLC](https://www.keypedia.com/companies/curewave-lasers-llc/c398e672-b95d-4b44-9571-eaf3718a2036)
- [SK Investment Inc d/b/a SK Novelty Wholesale](https://www.keypedia.com/companies/sk-investment-inc-dba-sk-novelty-wholesale/c0b59049-094d-458a-abbc-ab33afe52ed0)
- [NeuroDerm, Ltd.](https://www.keypedia.com/companies/neuroderm-ltd/9d6def4e-946b-43d9-813c-6f387ee1b993)

## Related Officers

- [Program Director](https://www.keypedia.com/people/ronald-m-pace/a79d2af4-650e-4220-8de1-92bbd284457d)